CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
CANbridge Pharmaceuticals Inc. has announced the resignation of Dr. Kan Chen as a non-executive Director and member of the audit committee, effective September 2, 2024. Dr. Chen’s departure is due to a desire to focus on personal commitments, with no reported disagreements or contentious issues related to his resignation. In his stead, Dr. Richard James Gregory will join the audit committee, as the company expresses gratitude to Dr. Chen for his service.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.